课题基金 / 基金详情

North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)

North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
北卡罗来纳州A
批准号:
7691356
负责人:
STEVEN A AKMAN
金额:
$10.32万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-25 至 2012-08-31

项目摘要

项目成果

STEVEN A AKMAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本P20提案介绍了维克森林大学综合癌症中心(WFUCCC)与北卡罗来纳州农业技术大学(NC A&T)生物和化学系之间的研究和教育合作关系。该伙伴关系的目标是:(1)促进WFUCCC和NC A&T之间的癌症研究合作,特别是关注癌症差异的研究,并通过与WFUCCC的合作和指导促进NC A&T少数癌症研究人员的职业发展;(2)培养NC A&T少数民族本科生和硕士生获得癌症生物学博士学位的兴趣。为了实现第一个目标,P20将为两个合作研究项目提供试点资金:(1)WFUCCC的Suzy Torti博士和Yong Chen博士将指导并与NC A&T的化学助理教授Marion Franks博士合作,进行一项合成和评估新型苯亚甲基作为前列腺癌化学预防剂的项目;(2)WFUCCC脑肿瘤中心主任Waldemar Debinski博士将指导并与NC A&T生物学助理教授帕特里克马丁博士合作开展一个项目,以了解转录因子Fra 1在胶质母细胞瘤细胞移动性和对治疗药物的抵抗中的作用。为了实现第二个目标:(1)选择上升,MARC,并在NC A&T融合程序本科生将参加湿实验室,计算生物学,或健康差距外展项目由WFUCCC教师指导;(2)每个试点项目团队将选择至少一个NC A&T硕士学位的学生;参与该项目。学生将被提供继续参与项目的选择,作为WFU癌症生物学的博士生;(3)WFUCCC和NC A&T教师将合作开发癌症基因组学和癌症动物模型的教学模块,用于NC A&T目前正在进行的课程。到P20结束时,预计:(1)弗兰克斯博士和马丁博士及其WFUCCC合作者将编写联合RO 1;(2)WFUCCC和NC A&T将编写R25桥接应用程序,以支持NC A&T学生在WFU癌症生物学博士课程中的入学。
英文摘要
DESCRIPTION (provided by applicant): This P20 proposal presents a research and educational partnership between the Wake Forest University Comprehensive Cancer Center (WFUCCC) and the Departments of Biology and Chemistry of North Carolina Agricultural and Technical University (NC A&T). The objectives of the partnership are: (1) to foster cancer research collaborations between WFUCCC and NC A&T, especially research focused on cancer disparities and to facilitate the career development of minority cancer research faculty at NC A&T through collaborations with and mentoring provided by the WFUCCC; (2) to foster interest in obtaining a PhD in cancer biology among minority undergraduate and Master's degree students at NC A&T. To achieve the first objective, the P20 will provide pilot funds for two collaborative research projects: (1) Drs. Suzy Torti and Yong Chen of the WFUCCC will mentor and collaborate with Dr. Marion Franks, Assistant Professor of Chemistry at NC A&T, on a project to synthesize and evaluate novel benzylidenes as prostate cancer chemopreventive agents; (2) Dr. Waldemar Debinski, Director of the Brain Tumor Center of the WFUCCC, will mentor and collaborate with Dr. Patrick Martin, Assistant Professor of Biology at NC A&T on a project to understand the role of transcription factor Fra1 in glioblastoma cell mobility and resistance to therapeutics. To achieve the second objective: (1) Selected RISE, MARC, and BLEND program undergraduates at NC A&T will participate in wet laboratory, computational biology, or health disparity outreach projects mentored by WFUCCC faculty; (2) Each pilot project team will select at least one NC A&T Master's degree student to ; participate in the project. The students will be offered the option of continued participation in the projects as PhD students in Cancer Biology at WFU; (3) WFUCCC and NC A&T faculty will collaborate to develop didactic teaching modules in cancer genomics and animal models of cancer for currently ongoing coursework at NC A&T. By the conclusion of the P20 it is expected that: (1) Drs. Franks and Martin and their WFUCCC collaborators will be writing joint RO1s; (2) The WFUCCC and NC A&T will be writing an R25 bridge application to support enrollment of NC A&T students in the PhD program in Cancer Biology at WFU.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2)
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2)
海外基金